The Claim
In patients with non-obstructive coronary artery disease, statin use is associated with a 40% higher likelihood of having a calcified plaque burden above the study median, independent of age, sex, diabetes, hypertension, obesity, and smoking.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among patients with non-obstructive coronary artery disease, those taking statins have a 40% higher chance of having a calcified plaque burden above the median level observed in the study population, after accounting for age, sex, diabetes, hypertension, obesity, and smoking.
See the scientific wording
In patients with non-obstructive coronary artery disease, statin use is associated with a 40% higher likelihood of having a calcified plaque burden above the study median, independent of age, sex, diabetes, hypertension, obesity, and smoking, suggesting a potential link between statin therapy and plaque composition changes.
Statin therapy lowers cholesterol in the blood, which reduces fatty deposits inside artery walls. This change causes cells in the plaque to transform into bone-like cells that lay down calcium, making the plaque harder and more stable.
What the research says
1 studyIn people with heart arteries that are narrowed but not blocked, those taking statins were more likely to have plaque with more calcium, even when accounting for other health factors like age and diabetes. This doesn’t mean statins cause calcium buildup, but they’re linked to it.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.